Raleigh Capital Management Inc. bought a new position in West Pharmaceutical Services, Inc. (NYSE:WST – Free Report) during the second quarter, HoldingsChannel.com reports. The fund bought 80 shares of the medical instruments supplier’s stock, valued at approximately $31,000. Other hedge funds have also recently made changes to their positions in the company. Vanguard Group Inc. […]